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Drug stability is one of the vital subjects in the pharmaceutical industry. All drug products 
should be kept stable and protected against any chemical, physical, and microbiological 
degradation to ensure their efficacy and safety until released for public use. Hence, stability 
is very important to be estimated or predicted.  
This work involved studying the stability of three different drug agents using three different 
mathematical models. These models included both empirical models (linear regression and 
artificial neural network), and mechanistic (kinetic) models. The stability of each drug in the 
three cases studied was expressed in terms of concentration, hardness, temperature and 
humidity. The predicted values obtained from the models were compared to the observed 
values of drug concentrations obtained experimentally and then evaluated by calculating the 
mean of squared. 
Among the models used in this work, the mechanistic model was found to be the most 
accurate and reliable method of stability testing given the fact that it had the smallest 
calculated errors. 
Overall, the accuracy of these mathematical models as indicated by the proximity of their 
stability measurements to the observed values, led to the assumption that such models can be 
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INTRODUCTION AND RESEARCH OBJECTIVES 
1. Introduction 
 
The drug as a chemical agent can easily be altered in its composition and characters with time 
under the influence of variable environmental and non-environmental factors. Such instability or 
degradation of a drug substance is of a great concern in pharmaceutical industry as can lead to 
partial or complete loss of its efficacy as a therapeutic agent or even a possible transformation 
into a hazardous substance. This fact made the stability of drug substances and drug products to 
be considered as an important subject in the field of pharmaceutical industry.  
Measurement of drug stability is as essential as defining its composition, method of manufacture 
as well as the drug specifications and ingredients. Drug stability usually requires vigorous work 
and lengthy studies to identify by drug companies. Studying and measuring of drug stability is 
one of the steps involved in the development process of any new product in the pharmaceutical 
industry which basically includes drug discovery, laboratory development, animal studies, 
clinical trials, and regulatory registration.  
Since the drug stability is a means of proving safety and efficacy, approval of any drug product 






1.1 Drug Stability  
 
Stability of a drug is defined as “the capacity of a drug substance or drug product to remain 
within established specifications to maintain its identity, strength, quality, and purity throughout 
the retest or expiration dating period” (1). It is crucial to maintain drug stability over an adequate 
period of time after its synthesis until its use to ensure achievement of the desired 
pharmacological effects. Instability of a drug may cause undesired change in its performance or 
leads to its failure. Given the fact that drug can degrade over time into a toxic substance, it is 
important along with measuring how much of the drug is lost to always identify the degradant. 
For example, tetracycline was found to degrade into epianhydrotetracycline which can cause 
Fanconi syndrome (2). 
1.2 Types of Drug Stability 
 
In fact, there are three modes of stability for any drug product: physical, chemical, and 
microbiological. These are briefly described as follows: 
1.2.1 Physical Stability 
 
This implies that the drug product remains unchanged throughout its shelf life with no alteration 
in its physical properties that include its appearance, organoleptic properties, hardness, 
brittleness, and particle size. This stability is essential to ensure drug efficacy and safety and 
should be maintained during all the stages of the drug product formulation, manufacturing, 
packaging and storage and closely monitored and evaluated via special tests that are decided 
according to the property of interest.  
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1.2.2 Chemical Stability 
 
This refers to the lack of any alteration in the chemical composition of the drug formulation. 
Generally, with time, most of the drug products can undergo degradation via chemical reactions 
such as hydrolysis, oxidation, and photolysis. Such reactions can lead to decrease in the active 
ingredient concentrations of the drug as well as formation of undesired by-products. This in turn, 
can cause the drug to have lower or no therapeutic effect or even to contain a harmful or toxic 
substance. The chemical degradation can also happen to preservatives and excipients contained 
in the drug products as well as their packages leading to the same unwanted chemical instability. 
It has been noticed that the solid dosage forms are more stable than liquid dosage forms since 
they undergo a slower chemical degradation.  
1.2.3 Microbiological stability  
 
This refers to the sterility of the drug formulation and lack of contamination by different types of 
microorganisms (e.g. fungi and bacteria). Obviously, microbial growth in a drug product can 
compromise its safety and lead to serious effects. Because of their high moisture content, 
solutions and water based semi-solids drugs are more liable to suffer from microbial 
contamination. This makes addition of antimicrobial preservatives to those drug dosage forms 
essential to ensure their sterility.  Moreover, to prevent contamination of the formulation during 
the storage, the container should be suitably designed preferably using a single dose container. 
1.3 Drug Shelf Life 
 
Shelf life or expiration date of a drug refers to the time interval that the average drug  
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characteristics such as strength and purity of the drug is expected to remain within the approved 
specifications after manufacture (3). 
Because of the existence of batch to batch variation, the true shelf life of different batches might 
differ and must be treated as a random variable, which depends on drug stability, temperature, 
humidity, exposure to light, and class of container among other possible variables. Thus, the 
design of any stability study should establish a shelf life that is applicable to all future batches of 
the drug manufactured under similar circumstances (4, 5). 
1.4 Food and Drug Administration Stability Guidelines 
 
The Food and Drug Administration (FDA) is the USA federal agency that is supervising the 
drug manufacturing and marketing. Through closely monitoring and validating the drug 
development process, FDA ensures that the drug product is safe and that it would remain stable 
and of no harm to customers throughout the whole period of the indicated shelf life (4).  
The FDA first required stability study testing in 1984. However, specific requirements on 
statistical design and analysis of stability studies for human drugs and biologics were not 
established until 1987 when the FDA guideline was issued. This was revised and expanded in 
1998. 
For every drug in the market, FDA requires that a shelf-life must be indicated on the container 
label. Moreover, the drug companies are required by the FDA to submit data that ensure the drug 
products will retain their identity, strength, potency and purity and demonstrate that the average 
drug characteristics can meet the approved specifications during the claimed shelf life period.   
As per the FDA stability gridline, the expiration date period is the time at which 95% one sided 
lower confidence bound for the mean degradation curve intersects the approved lower 
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specification limit. This applies for the drugs of which the degradation is expected to decrease 
with time in a linear fashion, See Figure [1.1]. If the time degradation relationship is not linear, it 
may be made so using an appropriate transformation (e.g. a linear, quadratic, or cubic function 
on an arithmic or logarithmic scale) (6). 
To overcome the problem of batch to batch variability in determining the expiration date, FDA 
stability guideline requires that three batches or more should be studied in order to estimate a 
more accurate single expiration dating period that can be applied to all future batches of the drug 
product. FDA also suggests that every drug product should be tested for stability at 3- month 
intervals during the first year, 6-months intervals during the second year and yearly thereafter 
(4). Since the containers as substances are in close contact with drugs, they can adversely affect 
the stability of the drug products. This fact made the FDA guideline suggest that containers such 
as bottles packages and vials should be included in the stability studies (7).                      
 
 





2. Research Objectives and Approach 
 
Drug stability is one of the most important aspects of any drug product in pharmaceutical 
industry. It is the drug stability that can decide its efficacy and pharmacological benefit to the 
consumers as well as the time after which it would lose its desired quality or even change into a 
toxic agent.    
As mentioned in the FDA guidelines, the purpose of stability testing is to provide evidence on 
how the quality of a drug substance or drug product varies with time under the influence of a 
variety of environmental factors such as temperature, humidity, and light. Several drug stability 
testing methods are used in practice to study the rate of drug degradation in order to estimate its 
expiration date. Most of these methods are based on analytical laboratory experiments which are 
usually expensive and time consuming.                                                    
A newer and a more efficient approach that is currently adopted for measuring the behaviour of 
the active ingredient through time is the use of statistical analysis. This implies formulation of 
statistical techniques and mathematical models where specific equations are used to study the 
drug stability and estimate its shelf life or expiration date.      
The mathematical models that are commonly used nowadays are the empirical models such as 
linear regression, artificial neural network, and the mechanistic models.  
In order to evaluate the applicability and efficiency of statistical modeling in studying drug 
stability and estimating its degradation with time and to know whether statistical modeling can 
efficiently substitute the ordinary analytical methods in studying drug stability several models 
were applied on three different drugs in this research. These drugs were chosen randomly from 
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different articles that were published in the pharmaceutical literature. The experimental data of 
these drugs were collected and all the three mathematical models (linear regression, artificial 
neural network, and mechanistic models) were applied on the data set of each of the three drugs 
to determine the best model to predict its stability. A comparison among these mathematical 
models was made at the end of this dissertation to conclude the best statistical method should be 



















BACKGROUND AND LITERATURE REVIEW 
  
2.1 Shelf Life Estimation 
 
The goal of shelf life estimation is to predict the time when the drug stability is no longer within 
the approved specification limit. Estimation of the expiration date of every newly released drug 
product in the market is one of the essential stages required by law to prove its safety in order to 
be licensed and released to the market. This stage is quite compromising because of the ethical 
implications and operational costs involved. 
Since the shelf life determines the length of time during which the drug product can be safely 
used, it should be estimated accurately. Labelling with an overestimated shelf life (expiry date) 
can lead to the use of product with an altered chemical composition which can cause unwanted 
or serious side effects to the patient. On the other hand, underestimation of the shelf life carries 
no risk to the consumers’ health. However, can lead to premature withdrawal of the drug product 
from the market and this can increase its cost and lead to financial losses (8).         
The expiration date period must be obtained through a rigorous experimental analysis with 
several batches of the product. The analytical procedures and conclusions derived from the 
analysis have to be closely monitored and well supervised. 
To predict the shelf life, accelerated studies are used for estimating the rate of chemical and 
physical degradation. To do this, the order of reaction has to be determined. For example, a zero 
order equation represents a linear relationship between the drug characteristic and time, whereas 
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in the first order the logarithmic transformation of the drug characteristic which is a linear 
function of time. After the order of the reaction is determined, the Arrhenius equation is then 
applied to decide the relationship between the rate of degradation and the temperature, as 
Arrhenius equation describes the linear relationship between log (degradation) and reciprocal of 
the absolute temperature (6). 
2.2 Statistical Models in Literature 
 
Statistical modeling as a new approach for drug stability studying in the pharmaceutical industry 
has attracted many researchers. Many articles have been published with regards to the use of 
statistical models in studying the drug product behaviour in terms of the chemical and physical 
decomposition as well as estimating the shelf life. 
In this section, several articles about drug stability study involving the use of mathematical 
modeling are summarized; 
Yang and Macdonald (9) applied both experimental and mathematical methods to determine the 
optimum pH that gives the highest stability for two of the factor Xa inhibitors (MLN1021 and 
CT54004). The rate of degradation of drug in solution formulation is mainly pH-dependent. 
Experiments after being prepared in buffer solution of widely variable pH (1-10) were first 
conducted on both compounds. Then the rate constants were obtained under different pH 
conditions while the drugs were stored at 60°C. It was found that the two compounds were most 
stable in water (i.e. at pH=1) and least stable under alkaline media. The stability then was 
decided by calculating the % drug remaining using HPLC analysis. 
The experimental rate constants were then used in setting up a kinetic model equation to 
determine the optimum pH. The optimum pH for each compound was predicted by plotting the 
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log degradation rate (logK) of each compound against the pH. The optimum pH for MLN1021 
and CT54004 were 6.18 and 5.92, respectively. These two values are very close to the 
experimental results which were 6.1 and 6.0 for MLN1021 and CT54004 respectively. The 
overall conclusion was that both experimental methods and mathematical models can give 
almost the same results and can be quite similar in assessing drug stability.         
As one of the commonly used mechanistic models in the pharmaceutical industry is Arrhenius 
theory. It has the advantage of rapidly assessing the stability and estimating the shelf life of the 
drug products under stress storage conditions. Gil-Alegri et al (10) applied Arrhenius theory to 
in stability testing of Mitonafide drug during development of both tablet and parenteral 
formulations. The degradation rate constant (k) under different storage temperatures was first 
determined. Then the correlation between the KT and the inverse of the storage temperature was 
evaluated and found to be statistically significant. This work showed that the stability prediction 
for this drug product can be reliably made by statistical methods. 
Anderson And Scott (11) performed an accelerated stability testing on 5 drugs of abuse 
(morphine, delta-9-THCC, amphetamine, phencyclidine, and benzoylecgonine) in order to 
estimate their shelf lives. The products were stressed by exposing them to variable degrees of 
high temperature and relative humidity. The degradation rate constants for each agent were 
calculated by using regression analysis. This allowed calculation of the activation energy; the 
amount of heat required for degradation to start by applying Arrhenius equation. 
Oliva et al (12) applied mechanistic modeling to study the stability of cholecystokinin fragment 
CCK-4 solution. HPLC method was used and experimental data were analysed by both 
isothermal and non-isothermal assays. For the non-isothermal studies, both the derivative and 
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integral parameters were used to estimate the Arrhenius parameters, whereas 2-step linear 
regression was used in the isothermal studies. The best model was then decided according to 
multiple statistical criteria and it was found that non-isothermal studies are faster and can give 
more reliable information about drug stability.                 
2.3. Drug Dosage Forms and Stability 
 
The stability of drug product with respect to physical, chemical, microbiological, therapeutic and 
toxicological characteristics is a dosage form specific that differs from one dosage form to 
another.  
FDA guideline requires specific tests of stability depending on the dosage form of the drug, that 
is, for every specific dosage form certain characteristics need be maintained throughout its shelf 
life to ensure its efficacy and safety. Hardness, brittleness and dissolution are examples of such 
characteristics that are mainly specific to solid dosage forms. Special tests are available to test 
these characteristics and are usually conducted during the drug manufacture process. Table [2.1] 
shows the different important drug characteristics for different dosage forms. 
Hardness is one of the important physical properties of the solid dosage forms. It is commonly 
used as a measurement for the tablet strength. The tablet strength should be evaluated during its 
formulation and manufacturing process to ensure its stability and resistance to breakdown 
throughout the different steps of packaging, shipping, and dispensing as well as the possible 
abuse by the consumer. Hardness in pharmaceutical industry is defined as the force required to 
break the tablet in diametrical compression test. This test implies placing the tablet between two 
anvils where one of the anvils is moved against the tablet until it breaks and the force at which 
the tablet breaks is the hardness (13, 14)   
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Table [2. 1]: Drug Characteristics for Different Dosage Forms 
Dosage form Drug characteristics 
Tablets 
Appearance, friability, hardness, color, odour, moisture, 
strength, dissolution,  
Capsules 
Strength, moisture, color, appearance, shape, brittleness, 
dissolution,  
Emulsions Appearance, colour, odour, pH, viscosity, strength  
Oral solution and suspensions 
Appearance, strength, pH, colour, odour, redispersibility, 
dissolution, clarity  
Oral powder Appearance, pH, dispersibility, strength  
MDI aerosols 
Strength, delivered dose per actuation, number of metered 
doses, colour, clarity, particle size, lose of propellant, 
pressure, valve corrosion, spray pattern  
Topical and ophthalmic 
preparations 
Appearance, clarity, colour, homogeneity, odour, pH, 
resuspendibility, consistency, particle size distribution, 
strength, weight loss     
Small-volume parenterals 
Strength, appearance, colour, particulate matter, pH, sterility, 
pyrogenicity 
Large-volume parenterals 
Strength, appearance, colour, clarity, particulate matter, pH, 
volume, extractables, sterility, pyrogenicity 
Suppositories Strength, softening range, appearance, dissolution 
 
Shelf life in most of the stability studies is related to the primary drug characteristics such as the 
strength. The strength of a drug product is defined as either the concentration of the drug 
substance or its potency which refers to the therapeutic activity of the drug product. FDA 
guideline considers the drug strength as a quantitative measure of the active ingredient of a drug 
product as well as other ingredients that require quantitation, such as alcohol and preservatives. 
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If a drug is designed to be used as an additive to another drug product such as parenterals or 
aerosols, FDA requires that stability study should be conducted on the dosage form made of the 
mixture of both drugs rather than each component alone. 
The stability of the characteristics of a drug product for a particular dosage form may be 
influenced by storage conditions, such as temperature, humidity, light, or air, and by package 
types such as high-density polyethylene (HDPE) (6).        
2.4. Factors Affecting Drug Stability 
 
To maintain drug stability, it is important to completely understand the drug structure and its 
characteristics along with the impact of different physical, chemical, microbiological, 
toxicological, and environmental factors upon the drug formulation (16). This ensures providing 
optimal storage conditions and modes of transportation of the drug products and identifying the 
precautions that should be taken to prevent or minimize the loss of activity. For example, 
knowing the effect of temperature on a certain drug can help avoiding its damage by keeping it 
under a suitable temperature during its storage and shipment (17). 
Basically, both environmental factors such as heat, moisture, light, and oxygen and product 
related factors such as formulation composition, manufacturing, and packaging can influence the 
drug product stability by inducing alterations of its physicochemical properties. Such influence 
can expedite the degradation of drug products (18). The degradation usually varies depending on 
the dosage form although different formulations can be influenced by the same factor quite 




2.4.1. Liquid Dosage forms 
 
Liquid dosage forms stability is influenced by the following factors: 
2.4.1.1. PH 
 
PH is the most important factor that can influence the rate of hydrolysis in liquid form. Some 
drugs undergo hydrolysis at a rapid rate in the presence of strong acids and bases and that is why 
it is important to determine the pH at which the stability is greatest. 
2.4.1.2. Temperature 
 
It was found that as temperature increases, the hydrolysis rate of drugs in solution profoundly 
increases. Some drugs would not be stable even at room temperature which makes it necessary 
to provide cool storage conditions to maintain drug stability. Examples of these drugs include 
injecting penicillin and insulin. 
2.4.1.3 Ionic Strength 
 
Some drug solutions require that electrolytes be added to adjust their tonicity. But this was found 
to have an impact on the stability.           
2.4.1.4. Solvent 
 
To avoid hydrolysis in some drugs, its water content can be replaced with a solvent such as 
alcohol or propylene glycol. However, if such a procedure is applied to other drugs, it can 






Since the presence of oxygen can induce oxidation, proper packing keeping the oxygen content 
of the solution less and leaving very little head space in the bottle above the drug products are 
methods to fight against oxidation. In some cases, oxygen can be replaced by nitrogen or carbon 
dioxide in the storage containers. 
2.4.1.6. Surfactant 
 
Nonionic, cationic and anionic surfactants when added to solution-containing drugs form micelle 
and the drug particles become trapped in the micelle. The hydrolytic groups such as OH cannot 
penetrate this micelle cover to reach the drug particles, and hence hydrolysis rate is decreased. 
2.4.2. Solid dosage form 
 
Solid dosage forms stability is influenced by the following factors: 
2.4.2.1. Moisture 
 
When water soluble solid drugs get exposed to moisture, they undergo decomposition in a 
similar way as the liquid dosage forms. For example, moisture can induce hydrolytic cleavage of 
ester or amide linkages in the drugs. Hence, the moisture should be avoided during manufacture 
and storage and packaging should be selected carefully.                           
2.4.2.2 Excipients 
 
The decomposition of the drug is found to be proportionally related to the water content of its 
excipients. Starch, povidone, and magnesium trisilicate are examples of excipients of high 
moisture content. Hydrolysis of aspirin in tablet form is increased because of magnesium 
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trisilicate. Also, the chemical interactions between the excipients in solid dosage forms can 
increase the degradation rate. Incorporation of polyoxyethylene glycols into aspirin suppository 
bases leads to its decomposition.         
2.4.2.3 Temperature 
 
Temperature can directly affect the drug or its excipients either directly by inducing melting or 
polymorphism. Temperature can also indirectly influence the drug decomposition through 
changing the relative humidity.    
2.4.2.4 Light and Oxygen 
 
Many drugs can undergo photodecomposition or oxidation and hence, such drugs should be kept 
away from light and oxygen. Since water contains oxygen, moisture should be avoided by 
storing the drugs under dry conditions.    
2.4.3. Semisolid Dosage Form   
            
The chemical stability of ointments and creams is mainly based on the base in their formulation. 
For example, hydrocortisone decomposes quickly in polyethylene glycol base making its shelf 
life to be only 6 months. Moreover, dilution of some highly potent ointments such as steroids to 
make them safer was found to influence their stability and hence, the choice of diluents should 
be made carefully. Also, the stability of these drugs can be influenced by their incorporation into 
gel structures by causing increased degradation. However, the viscosity has only a minimum 




2.5 Mechanism of Drug Degradation 
 
Drug products of different dosage forms such as liquid, solid, and semi solid dosage forms can 
usually undergo some form of chemical degradation or breakdown with time. Such change in the 
dosage form may change either the drug physical appearance such as discoloration or its 
chemical structure with consequent change in its potency or safety. Several modes of 
degradation have been identified ainclude; hydrolysis, oxidation, isomerisation, photochemical 
decomposition and polymerization. 
The mode of degradation that will take place is determined by the type of the chemical groups 




 Hydrolysis as a term means splitting in water. Hydrolytic degradation occurs for a drug that is a 
derivative of carboxylic acid or contains a molecular group that is based on this moiety such as 
an ester, amide, lactone, lactam, imide, or carbamate. Examples of such drugs include 
acetylsalicylic acid, physostigmine, and methyldopa.  
Hydrolysis can be catalyzed by Hydrogen ions (specific acid-catalysis) or hydroxyl ions 
(specific base-catalysis) and also by buffer that contain acidic or basic species.            
To stabilise the drug against acid-base catalyzed hydrolysis several ways are available. The most 
commonly one is to formulate the drug at a pH of maximum stability that is determined values. 
Hydrolysis can be also by the addition of non aqueous solvents such as alcohol, glycerine or 
propylene glycol. Making the drug less soluble is another method to suppress degradation and 
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this is done by using additives such as citrates, dextrose, sorbitol, and gluconate. Adding a 
compound that forms a complex with the drug or solubilisation of a drug by surfactants can 
increase stability of many drugs (17, 19). 
2.5.2 Oxidation    
 
This is another very common way of drug degradation. It can occur simultaneously with 
hydrolysis. Oxidation occurs by either loss of an electropositive atom, radical, or electron or 
addition of an electronegative atom or radical. Oxidation process usually involves combining 
oxygen with free radicals via quite slow chain reactions. These free radicals usually result from 
organic compounds by the action of light, heat or trace metals.  
Drugs that can degrade by oxidation include phenolic compounds such as morphine, phenyl  
epinephrine and catecholamine.  
One method that is commonly used to prevent oxidation and stabilize the drugs is to store them 
under anaerobic condition. This requires replacing oxygen in the containers with nitrogen or 
carbon dioxide. Also, since heavy metals such as iron, cobalt, and nickel can act as catalysts for 
oxidation process, avoiding the use of containers made from these metals during their storage or 
manufacture can be a protective method against oxidation. Other methods involve reducing the 
storage temperature and adding small amounts of antioxidants or reducing agents which were 
proven to be helpful in many cases. (17, 19, 20)                     
2.5.3 Isomerisation 
 
Isomerisation refers to the process of changing of drug into its optical or geometric isomers. 
Such isomers are usually of no therapeutic efficacy. As an example, adrenaline can undergo 
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racemisation where it converts from its levo-rotary form into less active isomer. Isomerisation 
can be catalyzed by low pH. Also, vitamin A can isomerise from its active form of all-trans into 
the less active cis-isomer. 
2.5.4 Photochemical degradation   
 
Light exposure can initiate chemical degradation of some drug products. The photochemical 
reactions can be either oxygen dependent (photo-oxidation) or independent on oxygen (such as 
dehydrogenation, rearrangement, and dimerization). Sodium nitroprusside which is a treatment of 
acute hypertension has to be protected from light. If the solution is protected from light, it is 
stable for at least 1 year; if exposed to normal room light, it has a shelf life of only 4 hours. 
Other examples of drugs that can rapidly degrade by ultraviolet light are phenothiazines, 
hydrocortisone, and ascorbic acid compounds. In some cases photochemical degradation can be 
manifested as discoloration of the drug.  
An efficient way to prevent photo-degradation of drugs is by the use of amber coloured glass 
containers for solution dosage forms. Other means include the use of cardboard outers, 
aluminum foil over wraps and film coating that can absorb light for tablets as well as storage of 
photosensitive drug products in the dark (17).                             
2.6. Stability Study 
 
Drug stability studies are conducted by drug companies to ensure that a drug can meet the 
approved specification prior to its expiration date printed on the package. Such studies are 




Generally, drug stability studies consist of a random sample of dosage units (e.g. tablets, 
capsules, vials) from a given batch or several batches placed in a storage room with controlled 
temperature and humidity conditions. 
Stability study involves taking a sample from several batches of a certain drug product and 
storing it under controlled condition then degradation is measured at fixed intervals such as 0, 3, 
6, 12, 18, 24 months and yearly afterwards, up to 5 years. The samples are not usually stored for 
more than 5 years because the maximum shelf life allowed by FDA is 5 years (1, 21).     
Even though the stability studies mainly aim at determining the shelf life, it usually helps 
towards providing evidence on how the quality of a drug substance varies with time under the 
influence of variety of environmental factors such as temperature, humidity, light, etc. Such 
information is used in determining the recommended storage conditions and retest periods as 
well (15). 
There are two classes of stability studies: accelerated and long term studies. 
2.6.1 Accelerated Stability Studies 
 
These are also known as short term studies or stress testing. The accelerated testing is considered 
as a practical and economic approach as it speeds up the rate of chemical or physical degradation 
of the drug product. And this can define the drug properties and estimate the tentative shelf time 
in a short term. This is conducted through exposing the drug to stressed condition by using a 
high level of special temperature (e.g., 50, and 75°C) and relative humility conditions (e.g., 75% 
or greater). Hence, the pharmaceutical companies are usually conducting such type of stability 
study especially in the early stage of a product development. The main purpose of accelerated 
stability testing is to estimate essential kinetic parameters, establish the relationship between 
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decomposition and storage conditions, and to establish a tentative drug shelf life for preparation 
and design of a long term stability study. The data obtained from accelerated testing are referred 
to as supportive stability data as opposed to the data resulting from the long term stability study 
which is known as the primary stability data. 
Accelerated testing should be carried out over a 6 month period and at a temperature that is at 
least 15 °C above the designated long term storage temperature as shown in Table [2.2] (6). 
Arrhenius regression model is the most commonly used statistical models for estimation of drug 
stability parameters in accelerated drug stability studies. 
2.6.2 Long Term Stability Studies 
 
The long term studies is carried out over a minimum of 12 months duration on at least three 
batches at the time of submission and should be continued for a period of time that is equivalent 
to the presumed shelf life. In long term studies, the drug product is stored at a room temperature, 
and humidity conditions, and stability testing is performed under regular environmental 
conditions. In practice, there is usually a batch to batch variation leading to variation in the 
estimated shelf life of different batches. For this reason, to estimate a single shelf life of the 
drug, combining data from different batches is preferred.   
Table [2. 2]: Temperature and Humidity in Stability Testing (6) 
Study Storage condition Minimum time period of submission 
Long term testing 25°C ±2°C/60%RH±5% 12 months 




2.7 Stability Testing 
 
Stability testing as a requirement by regulatory agencies is developed to determine the active 
ingredients of every newly made drug product in order to evaluate and provide assurance on 
detection of changes in its identity, strength, quality, potency and purity. 
2.7.1 Stability-Indicating Assay Methods 
 
In pharmaceutical industry, such testing procedures or assays are known as stability indicating 
assay methods (SIAMs) which are analytical methods that are employed for the analysis of the  
samples collected from stability studies (15). 
According to 1987 FDA guidelines, the stability indicating methods were defined as the 
“quantitative analytical methods that are based on the characteristic structural, chemical or 
biological properties of each active ingredient of a drug product and that will distinguish each 
active ingredient from its degradation products so that the active ingredient content can be 
accurately measured”. 
For a stability-indicating assay to be able to provide reliable data along with assurance on detection of 
changes in the drug products, guidelines require that SIAMs should be validated and suitable for 
the detection and quantitation of degradation products. To achieve such purpose, SIAMs are 
required to involve forced decomposition studies (stress testing) where the drug would be 
degraded under all types of severe stress conditions, such as extremes of PH, and light, 
oxidation, dry heat, etc. and separation of intact drug from degradation products. Moreover, the 
SIAMs are supposed to be able to analyze the degradation products (22, 23). 
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Bakshi and Singh (22) identified two classes of the stability indicating assay methods: i) The 
specific stability-indicating assay method, which refers to the method that is able to measure 
unequivocally the drug in the presence of all degradation products, excipients, and additives 
expected to be present in the formulation. ii) The selective stability indicating assay method 
which refers to the method that is able to measure unequivocally the drug and all degradation 
products in the presence of excipients, and additives expected to be present in the formulation. 
 
2.7.2 Techniques of Stability-Indicating Assay 
 
A review of literature shows that over the past 4 decades a large number of techniques have been  
commonly used in analysis of stability samples. These techniques mainly include titrimetric, 
spectrophotometric, and chromatographic as well as other miscellaneous methods   
1-titrimetric and Spectrophotometric 
These methods aims at the analysis of the drug under study alone in the matrix of excipients, and 
additives, degradation products, impurities, etc., and also other drugs in case of the combination 
products. They are not expensive and simple to perform but rarely used because of limited 
sensitivity and specificity. 
2- Chromatographic 
This technique is widely used in the analysis of stability samples thanks to its advantage of 
separating multiple components as well as its high accuracy and sensitivity for even small 
quantities of degradation products produced. Chromatographic methods that are commonly used 
include: thin-layer chromatography (TLC), high performance thin layer chromatography 
(HPTLC), gas chromatography (GC), high performance liquid chromatography (HPLC), and 
newer technique like capillary electrophoresis (22).  
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As an example of HPLC application; Mohammadi et al (24) developed a validated stability-
indicating HPLC analytical method for the determination of Oristat in API and dosage forms. 
The results of stress testing undertaken according to the International Conference on 
Harmonization (ICH) guidelines reveal that the method is selective and stability-indicating.  The 
proposed method is simple, accurate, precise, specific, and has the ability to separate the drug 
from degradation products and excipients found in the capsule dosage forms. The method is 
suitable for use for the routine analysis of Orlistat in either bulk API powder or in 
pharmaceutical dosage forms. In addition, the HPLC procedure can be applied to the analysis of 
samples obtained during accelerated stability experiments to predict expiry dates of 
pharmaceuticals. 
3- Miscellaneous 
The famous example is proton nuclear magnetic resonance (NMR) spectroscopy. 
Bakshi and Singh (22) proposed a systematic approach for the development of a stability-
indicating method by following these steps: 
Step 1: Critical study of the drug structure to assess the likely decomposition route(s) 
Step 2: Collection of information on physicochemical properties. 
Step 3: Stress (forced decomposition) studies 
Step 4: Preliminary separation studies on stress samples 
Step 5: Final method development and optimization 
Step 6:  Identification and characterization of degradation products and preparation of standard 





2.7.3 Analytical Method Validation 
 
Validating the stability-indicating assay methods is a vital step in stability testing. Without 
validation, analytical method can fail to accurately study the degradation of the drug product 
over time. Also, it may not be able to accurately estimate the drug expiration dating period. 
Hence, the regulatory agencies required that any new assay methods to be validated and 
documented with sufficient laboratory data and information. Thus validation is considered as the 
process by which the analysis methods are proven through laboratory studies to have the 
performance features that comply with the intended analytical applications. 
A set of analytical validated parameters were suggested by the USP-NF (United States 
Pharmacopeia –National Formulary) which are: accuracy, precision, limit of detection, limit of 






STABILITY MODELLING AND TECHNIQUES 
 
The main aim of this chapter is to introduce the statistical techniques that will be used in 
modelling of drug stability studies. 
Process controls in pharmaceutical industry is mainly based on statistics as a means of drug 
behaviour under variable environmental conditions. Several statistical techniques (process 
models) are applied in the analysis of different process variables and estimation of unknown 
parameters. 
It is crucial to use a suitable process model depending on the complexity of the process control 
and the number of equations involved. Ideally, the model should take into consideration all the 
important dynamic behaviour with a reasonable number of equations, variables, and parameters.  
Two types of models are widely used in practice: empirical and theoretical models. These 
models differ in their applications advantages and process of their development.                
3.1 Empirical Models 
 
Empirical models are developed from experimental data. They are the ideal models to use for 
complex processes that involve large number of equations and process variables and many 
unknown parameters such as physical and chemical properties. Compared to theoretical models, 
empirical models are simpler and easier to develop. Another advantage is that the computational 
time needed for the model solution is much shorter than the actual process response time. 
However, one disadvantage of empirical models is their inability to extrapolate well.                  
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Estimation of unknown model parameters and Comparison between several mathematical 
models can be achieved by statistical analysis (26).  
3.1.1. Regression Analysis   
 
Regression analysis is a statistical procedure for estimating the average relationship between the 
dependent variable, such as label claim and one or more independent variables like, time, pH, 
temperature etc. (27). Regression analysis is one of the most commonly and extensively used 
statistical methods in wide spread areas including chemicals and pharmaceuticals (28, 29). 
Regression analysis attempts to find a line of best fit so that the squared deviations of the 
observed points from that line are minimized. Thus, this general procedure is referred to as least 
squares estimation (29).  
3.1.1.1 Simple linear Regression 
  
Linear regression is concerned with models linear in parameters. Simple linear 
regression involves only one independent variable, like temperature and the linear relationship 
equation is given by  
  110 xy                                                                                                                         [eq3.1] 
Where the intercept
0 & slope 1  are unknown linear parameters, called regression coefficients, 
y and x are dependent and independent variables respectively.  
3.1.1.2 Multiple Linear Regressions 
  
Multiple regressions involve two or more independent variables. A multiple linear regression 
model that might describe the relationship is:                               
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  kk xxxy ...22110                                                                                           [eq3.2] 
where y denotes the response (dependent variable) and
1x to kx  represents the regressors 
(independent known variables). 
 
The random error term   is assumed to follow the normal distribution with a mean of 0 and a 
variance of 2 and the errors are not correlated, that is, statistically independent. 
The term linear is used because the equation [eq3.2] is a linear function with respect to unknown 
parameters ( ),...,, 10 k .  
The unknown parameters of the model, Eq. [3.2], are estimated by minimizing the sum of 
squares of the differences between the observed (experimental) values y and the fitted or the 
predicted value ŷ  from the model to provide a good fit. So, the least-squares estimator of   is: 






































































































Since the matrix       is non-singular, its inverse is present. This matrix       will present if the 
regressors are linearly independent, that is, a column of the X matrix is not in linear combination 
with the other columns. 
Since    is an estimator of   therefore, the estimate of the vector y can be calculated as: 
̂ˆ Xy                                   [eq3.4] 
And the model predictions are given by: 
ŷ =   1 +   2 1x + ... +   kk x                                                                                                                     [eq3.5] 
Multiple linear regression models are often used to fit empirical models (predictive models) 
which are obtained by fitting observed (experimental) data set of y and X values. After 
developing such a model, if an additional value of X is then given without its accompanying 
value of y, the fitted model can be used to make a prediction of the value of y. (26). 
3.1.2. Regression Diagnostics 
 
3.1.2.1 Residual Analysis 
 
Residuals ei are defined as the difference between actual observation value of the dependent 
variable yi and the predicted value  i computed from a regression model.  
ei = yi -  i, i = 1, 2 ,.....,n,                                                                                                        [eq3.6] 
Residual analysis is helpful to assess the adequacy of the fitted regression model and assess the 
assumption that the errors are uncorrelated random variables and normally distributed with mean 




3.1.2.2 Residual Plots: 
 
Plot the residuals to check whether the regression model represents the data correctly. If so, the 
residuals should be normally distributed with a mean equal to zero. If the residuals are 
distributed with a trend or pattern, the model is then considered inappropriate.  
For assessment of regression models by residual plots, the following steps are to be followed: 
1- A miss-specified model can be identified by plotting the residuals (yi -  i) against each 
independent variable (x) in the model. When a plot has a curvilinear trend, this indicates 
that the model adequacy could be improved by presence of a quadratic term. 
2-  An unequal variance can be identified by plotting the residuals (yi -  i) against the 
predicted values ( i). 
3- Non normal errors can be identified by constructing a histogram for the residuals. 
Extreme skewness in the histogram can imply presence of outliers. 
4- Outliers can be identified by plotting the residuals (yi -  i) against the predicted values 
( i) to locate the ones that are located at 3x standard deviation ( or more above or below 
0. Outliers can be due to coding or recoding errors. i.e. error while recording the data or 
measrument. Usually, if they don’t influence the model, they can be ignored. 
5- Correlated errors are determined by plotting the residuals in time order (30).       




Coefficient of determination R
2 
refers to the ratio between the regression sum of squares (SSR) 
and the total sum of squares (SST) and it indicates what percentage of the variation present in 
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                                                                                      [eq3.7] 
Where SSE is the error sum of squares, SST is the total sum of squares and SSR is the regression 
sum of squares. 
It is also defined as the fraction of the variation in the data that is explained by all the regressors 




                                  
        
                                                                                [eq3.8] 
Coefficient of determination values range between 0 and 1. The value approaching 1 indicates 
that the regression model explains the data very well (29). If the regression line passes exactly 
through every point on the scatter plot of data, it would be able to explain all of the variations. 
The further the regression line is away from the points, the less it is able to explain a variation 
among data. 
It is well known that it is possible to make R
2
 equal to one by adding more terms to the fitted 
polynomial. The statistic R
2
 cannot be used to judge the adequacy of the fitted model when 
nested models are compared. Two models are nested if both contain the same terms and one has 
at least one additional term. Instead, one should use the mean square errors of the two compared 
models to choose the model with best predictability. However, one can use R
2
 to discriminate 
between non nested models (26).      
3.1.3. Artificial Neural Network (ANN) 
 
Neural network as a term has derived originally from artificial intelligence (AI) research. The 
main goal of AI was to develop computers that are capable of solving problems through the use 
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of symbolic non algorithmic methods. Neural network is one of the main major AI- based 
techniques that is widely used in computer engineering as well as chemical engineering reactors, 
and also it has non-engineering applications such as medical diagnosis, stock market analysis, 
and cheese strategies.   
The great significance of neural networks is attributed to its applicability to model complex 
processes with large input-output data set when the real model is not known, as well as its high 
efficiency in time and effort saving. Moreover, NN plays an important role in modelling non-
linear systems (26).  
Robert Hecht-Nielson (1990) defines a neural network as “a computing system made up of a 
number of simple, highly interconnected nodes or processing elements, which process 
information by its dynamic state response to external inputs”.                                                        
The neural network works in a similar way as the human brain where the nervous system 
performs its function through interaction between multiple components and complex pathways. 
The process starts at special receptors in human body which receives the stimuli (input) and then 
transmit them to the brain via neurons. In the brain, other neurons process this information and 
produce output that is usually based on the brains past experience. Similarly, ANNs function 
through setting up fixed systems by which certain outputs are produced from specific inputs 
(32). 
To ensure accuracy of the resultant output, every neural network should undergo a training 
process during which a set of data are tried first several times to confirm the presence of real 
relationship between the process input and output. The next step will be then to make sure that 
the desired relationship was learned (33). 
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3.1.3.1 Artificial Neural Network Structure 
 
The ANN, as it is shown in Figure [3.1] is composed of three different layers: inner layer, hidden 
layer, and an output layer along with highly interconnected network of nodes. All these layers 
are composed of one or more neurons (32). One of the common types of NNs is a feed-forward 
network in which a neuron in each layer is connected to all neurons in the next layer. (33).   
 
   
   
   
         Input Layer               Hidden Layer          Output Layer 
 
Figure [3. 1]: A typical Neural Network Formed by an Interconnection of Nodes (32) 
The node is the basic structure of NN that functions as the processing element which performs 
most of the calculations. The node receives and manipulates the NN inputs to give the output. 
There are three factors that determine the output: weight factors Wj, internal thresholds Tj, and 
transfer function f . The Figure [3.2] shows the structure of neuron that transfers the input ai to 
the j
th
 output bj through a weight factor Wj and a transfer function f(xj). jT
 





Figure [3. 2]: Schematic Display of Neuron (26) 
                                                      
Every link between two neurons has a specific weight that represents the strength of their 
connection. These weights are unknown parameters that need to be estimated out of the 
modelling process by using input and output data set (26). As shown in the following equations, 
when such weights are multiplied by their inputs and summed together followed by subtracting 
the internal threshold, the total activation will result. This total activation is then applied to a 
transfer function to calculate the output. The following equations are given below         
Total activation ji
i
ijj Tawx                   [eq3.9] 
The output of the neuron can be shown as: 
)()( ji
i
iji Tawfxfz                                         [eq3.10] 
Where; f is the transfer function.  The most commonly used functions are sigmoid, hyperbolic 
tangent and the radial basis functions. Mathematicians and computer scientists found the 
sigmoid, hyperbolic tangent to be very useful for prediction purposes, whereas the radial basis 
functions were considered to be the most efficient in classification networks. However, any 
functional form can be used such as square root, log, e
x
, etc. (32). 
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It is very important to normalize the inputs and the outputs to avoid any false influence of factors 
with higher magnitude when they are not of the same order of magnitude. 









      
                                                                                                              [eq3.11]
 
Where x̂  is the normalized value, and xmin and xmax are the minimum and maximum values of x, 
respectively. x can be either input or output variable. 
Two steps are considered in the developing of artificial neural network model. The first step is a 
training stage, where the network is exposed to training set of inputs and outputs to learn the 
relationship between input and output variables. The second step is considered as a testing stage, 
where the function of the network is tested on patterns that the network has not been subjected 
during the training stage. So, the trained network can be used to predict the output for data points 
that were not used in training the network (34).  
3.1.3.2 Back Propagation Algorithm  
 
Different algorithms can be implemented to adjust the weights in order to map input-output 
correctly.  One algorithm which has greatly contributed to neural network notoriety is the back-
propagation algorithm. This algorithm involves an iteration search where the weights from 
output layer are adjusted back to input layer in each run. This process is repeated until no further 
improvement in the mean squares error (MSE) value is found.  
36 
 
 Feed-forward interlayer connections are required for back propagation where each layer feeds 
into the following layer subsequently. The back propagation algorithm relies on the error-
correction learning that is an optimization process using steepest gradient descent principle (35). 
3.2. Theoretical (Mechanistic) Models 
 
Theoretical models are established by using the principles of chemistry, physics, and biology. 
The advantages of these models represent in their applicability in many different conditions. 
They can lead to a great deal of understanding of the physical behaviours. However, the fact that 
their development can be expensive and time-consuming is considered as a disadvantage. 
Moreover, in case of complex processes, some theoretical model parameters such as reaction 
rate coefficients, physical properties or heat transfer coefficients are usually unknown. 
Generally, theoretical models of chemical processes follow ordinary differential equation (ODE) 
and/or partial differential equation (PDE) along with algebraic equations. Through these 
equations, these models allow a reasonable extrapolation and estimation of unmeasured variables 
that can’t be achieved. Theoretical models are formulated by using unsteady-state conservation 
laws such as the conservation of mass and energy.  
 Conservation of mass       
{Rate of mass accumulation} = {rate of mass in} – {rate of mass out} 
 Conservation of component i 
{Rate of component i accumulation}= {rate of component i in} – {rate of component i out} ± { 
rate of component i produced or consumed} 
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 Conservation of energy 
{Rate of energy accumulation} = {rate of energy in by convection and conduction} – {rate of 
energy out by convection} + {net rate of heat addition to the system from the surrounding} + 
{net rate of work performed on the system by the surrounding} (26) 
3.2.1 Kinetics of Chemical Reactions 
  
Understanding the kinetics of the drug decomposition is important for the shelf life prediction 
(17). The rate of change in the concentrations of the reactants and products can be used to 
characterize the rate of a chemical reaction. 
General chemical reaction equation                                         
The rate of disappearance of reactant A, -rA, is dependent on concentration and temperature. 
 
   
  




                                                                                                        [eq.3.12] 
where; 
  
   
  
  is the rate of chemical decomposition A with respect to the time. 
 k is the reaction rate constant and its unit depends on the order of the chemical reaction. 
CA & CB are the concentrations of the reactants A and B, respectively. 
α & β are the partial orders of the reaction and they are determined experimentally.  




3.2.2 The Order of the Reaction  
 
The decomposition reaction of the drugs can be a simple that falls under the category of one of 
the well known reaction orders namely; zero, first, second and third order reactions. However,  
most of the drugs decompose through multiple steps or complex reactions. 
If the general degradation reaction of a drug product is                         
The reaction rate is 
  
  
 = - k CA
α
                                                                                        [eq3.13] 
3.2.2.1 Zero-Order Reaction: 
The rate of the drug product degradation 
  
  
 is independent on the initial concentration of the 
reactant.  
The reaction rate equation is given by the following; 
the differential equation form is   
   
  
 = - k0, and                                                             [eq3.14] 
the integrated form is                   CA = CA0 – k0t                                                                [eq3.15] 
where; 
CA0 & CA are the concentrations of the drug at time zero and time t, respectively. 
k0 is the zero-order rate constant and its unit is, for example,  
    
            
  
The linear relationship between the concentration CA and time t is obtained in the zero-order 
reactions. Acetyl salicylic acid hydrolysis follows zero order kinetics (17, 36). 
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3.2.2.2 First-Order Reaction  
The rate of the degradation of a drug product 
  
  
  is dependent on the initial concentration of the 
reactant. 
The reaction rate equation is given by; 
The differential equation form is  
   
  
 = - k1CA                                                                 [eq3.16] 
The integrated form is                  CA= CA0 exp (-k1t)                                                          [eq3.17] 
The first order equation can be written in a linearized form; 
lnCA= lnCA0 – kt                                                                                                                   [eq3.18] 
Where;  
lnCA0 and lnCA are the natural logarithm of the concentration at time zero and time t, 
respectively. 
k1 is the first-order rate constant and its unit, for example, is  
 
      
  
The linear relationship between the logarithmic concentration lnCA and the time t is obtained in 
the first-order reaction. Drugs that hydrolyse in solution usually follow first order reaction (17)    
3.2.2.3 Second Order Reaction 
The reaction rate equation is given by; 
The differential equation form is  
  
  
 = - k2CA
2
                                                                  [eq3.19] 





   




CA0 & CA are the drug concentrations at time zero and time t, respectively. 
K is the second-order rate constant and its unit, for example, is 
     
           
 
The linear relationship between the reciprocal concentration 
 
  
 and time t is obtained in the 
second-order reaction (36)  
 3.2.3 Arrhenius Regression Method 
 
Arrhenius regression model is the most commonly used statistical models for estimation of drug 
stability in accelerated drug stability studies. Its function is to develop a relation between rate 
constant and temperature to estimate the potential shelf life of a drug product during the early 
stages of its pharmaceutical development. By this method, the effect of temperature on chemical 
stability as well as the effect of a catalyst on decomposition can be predicted. The Arrhenius 
method is expressed mathematically by the following equation: 
 k(T) = A × exp (-Ea/[R×T])                                                                                              [eq3.21] 
ln K= ln A -Ea/[R×T]                                                                                                           [eq3.22] 
where: 
 T = Temperature (Kelvin) 
R = 1.987 (Rate Gas Constant, cal/mol.k) 
Ea = Activation Energy (cal/mole) 
A = Frequency Factor 
k(T) = Rate Constant of any order as a function of absolute temperature  
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Arrhenius method has been traditionally used to describe the temperature dependency for 
various chemical reactions by regarding Ea and A to be independent of temperature. 
One of the most important applications of Arrhenius equation is to predict the drug stability at 
room-temperature or any lower or slightly upper temperature from accelerated data. This can be 
accomplished by; firstly, determining the corrected order of the degradation reaction 
experimentally in order to describe the functional relationship between the drug concentration 
and time and obtain the degradation rate constants (k) at different temperatures; secondly, setting 
up the Arrhenius equation relates the logarithm of reaction rate linearly against reciprocal of the 
elevated temperature to determine the activation energy and the frequency factors. 
This method has been successfully applied to estimate the shelf life and predicting the stability 
of various pharmaceutical drug products (2). 
The next chapters 4, 5, and 6, will present three case studies related to three different drug 
products that were taken from pharmaceutical articles. On each drug, different empirical and 
kinetic mathematical models were applied. The predicted values obtained from these models 
were then compared with the observed values available from experiments. 
The smaller the differences (or the so called errors) between these two values, the more reliable 
the predicted values. Hence, depending on the value of these errors, one can firstly decide which 
model is the best among the three and secondly, whether statistical modelling techniques can 




STABILITY OF ASPIRIN TABLETS 
 
In this case study, the experimental data for the stability of acetyl salicylic acid (ASA) tablets 
were taken from the article “Stability of Aspirin in A Moisture Containing Direct Compression 
Tablet Formulation” by Michael, et al (37). 
In this experiment, ASA was mixed with a mixed-sugar diluent containing about 8% moisture 
for 20 minutes and then blended after adding stearic acid for 3 minutes. A part of the blend was 
compressed into tablets. Both tablets and uncompressed powder blend were packaged into 
separate glass bottle containers. Stress stability studies were conducted on the compressed 
tablets (10 tablets per bottle) and the powder blend (3 grams per bottle).           
The bottles of tablets and powder blend were stored under different temperatures 35, 40, 45, and 
50 
°
C) for different time intervals then the stability of these drug samples was assessed according 
to the rate of decomposition. Each time, the content of each bottle rinsed and ground with 
acetonitril and then filtered and assayed for ASA remaining by using stability indicating 
simultaneous UV assay. 
It was concluded by this experiment that aspirin degradation is accelerated with time and with 
temperature increment. The rate of degradation was found to be following the emperical 
equation:  y = 100 – Kt
n
; where y is the % ASA remaining, t is the time, and k and n are 
constants. The formulation tested proved good stability with only < 1% degradation after 1.75 
years at room temperature. Moreover, the moisture content in this formulation had no influence 
on the decomposition rate without an obvious explanation. 
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4.1 Experimental Data: 
 
Experimental data on Aspirin stability were collected and all the three mathematical models 
(linear regression, artificial neural network, and mechanistic models) were conducted on these 
data to determine the model that best predicts its stability. A comparison among these three 
mathematical models was made at the end to conclude the best statistical method that should be 
adopted in practice to achieve the most accurate shelf life. 
Table [4.1] shows both independent variables (temperature and time) and dependent variables 
(percentage of ASA remaining).  
Table [4. 1]: Effect of Temperature and Time on the %ASA Remaining 







%ASA Remaining Y 
50 323 1.19023 98.5603 
50 323 4.12644 96.5046 
50 323 7.13936 92.0614 
50 323 10.1548 86.7537 
50 323 13.8791 77.577 
45 318 1.25856 99.0543 
45 318 7.2619 97.9072 
45 318 14.1113 93.7145 
45 318 20.188 91.3324 
45 318 26.2672 88.0858 
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45 318 30.1097 86.278 
40 313 1.25749 99.4248 
40 313 9.14346 98.6499 
40 313 15.2181 96.9676 
40 313 20.1743 96.0253 
40 313 44.1901 90.6133 
35 308 1.25749 99.4248 
35 308 14.235 99.1485 
35 308 20.2368 98.5365 
35 308 35.1707 97.274 
35 308 45.9181 96.1724 
 
4.2 RESULTS AND DISCUSSION: 
 
4.2.1 Linear Regression 
 
As it is known, the linear regression model is concerned with models that are linear in 
parameters. In this experiment, the values of the independent variables are perfectly known and a 
linear model was created to estimate the unknown parameters. 
The coefficient of determination was found to be 84.67% and the standard error was 2.51 as it is 




Table [4. 2]: Statistical Results of Regression Model 
Regression Statistics 
Multiple R 0.920195 
R square 0.846759 
Adjusted R square 0.808449 
Standard Error 2.51667 
Observations 21 
 
Table [4. 3]: ANOVA Table 
Source of variance DF SS MS F critical F Significance  
Regression 4 559.9597 139.9899 22.10265 2.36E-06 
Residual 16 101.338 6.333626   
Total 20 661.2977    
 
The underlying model: 
The following table [4.4] represents the parameters that have significant effects as has been 
found from ANOVA table. 





t observed P-Value Lower 95% Upper 95% 
Intercept       (β0) -8803.22 2618.405 -3.36205 0.003965 -14354 -3252.45 
Temp K        (β1) 56.55087 16.53652 3.419757 0.003511 21.49502 91.60672 
Time             (β2) 17.26145 3.327954 5.186805 9E-05 10.2065 24.31639 
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Temp*Time  (β3) -0.05608 0.010653 -5.26406 7.71E-05 -0.07866 -0.03349 
Temp square (β4) -0.08977 0.026101 -3.43942 0.003368 -0.14511 -0.03444 
tcritical =2.05183 
General regression model   
  =β0 + β1X1 + β2 X2 + β3 X1X2 + β4 X2
2
+ ε                       where   ~N (0, 2) 
Fitted linear regression model  
 = - 8803.22 + 56.55087 X1 + 17.26145 X2 – 0.05608 X1X2 – 0.08977 X2
2
 +   
Model evaluation: 
To test the validity of the underlying assumption (error ~N(0, 2) as a diagnostic check, we are 
going to look at the residuals and normal probability plots from the fitted model. Also 
determining the coefficient of determination to measure how well the linear regression model 
represents the data.  
 Residual plots 
Using the residual plots is to investigate whether the errors are scattered, independent and 




Figure [4. 1]: Aspirin Residual Plots 
We can see from the Figure 4.1 that the residual has a random pattern. 
 Normal probability plot: 
Using normal probability plots to investigate whether the error are normally distributed. See 
Figure [4.2]. 















Figure [4. 2]: Aspirin Normal Probability Plot 
Shown in Figure [4.2] is that the normal probability plot shows a straight line. So, we can 
conclude that the observed sample comes from a normal distribution. 
 Coefficient of Determination (R2) 
Using the coefficient of determination as a diagnostic check is to measure whether the regression 
line represents the data. 
From the results, it is shown that R
2 
= 0.8467, which means that 84.67% of the total variation in 
observed sample can be explained by the linear relationship between the regressors and observed 
response (as described by the regression model).  The other 15.3241% of the total variation in 
the observed sample are unexplained. 






















4.2.2 Artificial Neural Network (ANN) 
 
Back propagation feed forward based on Levenberg-Marquadt training algorithm was employed 
to train the network. MATLAB® neural network toolbox was used to train and simulate the 
network model. Log sigmoid was found to give reasonable response.  
The data was randomly divided into a 15 training set and a 6 testing set as shown in Tables [4.6] 
and [4.7]. About 10 – 15 % of the data was selected randomly to be the testing data set. Then 









     
So that, the inputs and outputs are belong to the interval [0, 1].  
Table [4. 5]: A Training Data Set of Aspirin                      
Training Data Set 
Temperature(K) Time (Weeks) ASA remaining % 
323 7.1394 92.0614 
318 20.1880 91.3324 
318 1.2586 99.0543 
318 7.2619 97.9072 
313 20.1743          96.0253 
313 9.1435 98.6499 
318 30.1097 86.2780 
323 13.8791 77.5770 
308 35.1707 97.2740 
308 20.2368 98.5365 
318 14.1113 93.7145 
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313 44.1901 90.6133 
308 14.2350 99.1485 
308 45.9181 96.1724 
308 1.2575 99.4248 
 
Table [4. 6]: A Testing Data Set of Aspirin 
Testing Data Set 
Temperature(K) Time (weeks) ASA remaining % 
323 1.1902 98.5603 
323 4.1264 96.5046 
323 10.1548 86.7537 
318 26.2672 88.0858 
313 1.2575 99.4248 
313 15.2181 96.9676 
 
The result was acceptable by using 300 epochs of training, with the goal 10
-4
 and 10 neurons and 
one hidden layer. Tan sigmoid functions were applied in this set of data. 
The coefficient of determination (R
2
) was 72.016% for training data set and 98.756% for the 
testing data set as shown in Tables [4.8] and [4.9], respectively. Since R
2
 approaches 1, it 





Table [4. 7]: Statistical Properties for the Training Data Set 
Average error 1.94692 
Maximum error 10.87060 





Table [4. 8]: Statistical Properties for the Testing Data Set 
Average error 3.88989 
Maximum error 10.87060 

























As it is shown in Figure [4.3], the parity line passes through almost all the observed and 
predicted values on the scatter plot. This indicates high accuracy of the predicted values with 
close proximity to the observed data.    
 
Figure [4. 3]: Parity Line Plot for Aspirin Training Datasets 
 








Parity Line Plot 
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Since there was no enogh data to be used both for training and testing, it wasn’t possible to 
clearly show how close the predicted values are to the observed. This can be seen in the Figure 
[4.4] where the straight line does not pass through all the points. However, the points fall close 
to a parity line. 
 
 
Figure [4. 4]: Parity Line Plot for Aspirin Testing Datasets 
 
 


















Figure [4.5] shows the distribution of the errors. Most of the errors lie in the range between 0-
1%.   
 

















4.2.3 Mechanistic Model 
 
Microsoft Office Excel© version 2007 was used for mechanistic model calculations in this 
research. The determination of degradation kinetic orders as well as the reaction rate constants 
was attempted. A mechanistic model for Aspirin was propose as shown in the Equation [4.1] and 
both of the rate constant and the rate order were determined at different temperatures using a 
linear regression method.  
-ra = kA CA
α
                                                                                                                           [eq4.1]                                                       
Equation [4.1] was linearized as: 
ln (-ra) = ln (kA)+α
 
lnCA                                                                                                                                     [eq4.2] 
The results are summarized in the following Table [4.9]. 
Table [4. 9]: The Reaction Rate Constant (k) for Aspirin Degradation at Various 
Temperatures 
Temperature(K) Reaction rate constant kA (Week
-1




318 0.053547 0.9428 
313 0.027645 0.9681 
308 0.003763 0.92 
 
The hydrolysis process of aspirin was found to follow first order kinetics. The mean of squared 
error was found to be 2.92X10
-7
 and the coefficient of determination was 96.48%.  
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The natural logarithm of observed rate constants over the temperature range of 40-63°C were 
plotted versus reciprocal of temperature according to the Arrhenius equation to calculate the 
frequency factor and the activation energy. The activation energy was calculated from the slope 
of the straight line obtained by linear regression method and found to be approximately 49 
















STABILITY OF AMOEBICIDE DILOXANIDE FURATE DRUG 
 
Diloxanide Furoate (DF) is a luminal Amoebicide. After being administered orally, it gets 
hydrolyzed to produce active ingredient; diloxanide in the gastrointestinal tract. Hence, its 
function requires it to remain stable in the gut where different PH media is encountered. 
A study was performed by Gadkariem, et al (38) on DF stability at different temperature in 
alkaline media using a stress stability study and Arrhenius regression equation for prediction of 
its shelf life and in order to obtain a drug with a better formulation and design.       
In this experiment, the standard solution was prepared by diluting 200 μg ml
-1
 of DF solution in 
methanol with phosphate and alkaline borate buffers and the kinetic of drug degradation was 
controlled by HPLC method. Initially, the pH-rate profile for the hydrolysis of DF at 40°C (pH 
range 7.0-10.0) was studied by plotting the log of remaining drug versus time. The effect of 
temperature on DF solution stability was then studied. Four 50-ml flasks were each filled with 
5ml of DF solution (200 μg ml
-1
) and an alkaline borate buffer (pH=8.0). The rate of drug 
hydrolysis was studied at various temperatures (40, 50, 55 and 63°C) using HPLC method. 
When they plotted the log % remaining drug versus time (0-100 minutes), the hydrolysis process 
was found to follow first order kinetic with an estimated activation energy of hydrolysis of 18.25 
Kcal.mol
-1
.   
This study concluded that the DF drug decomposes in solutions by hydrolysis process that is 
temperature and pH dependent. The three DF decomposition products are diloxanide (the active 
drug), furoic acid, and methylfuroate. They were identified by using HPLC, TLC, mass 
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spectrometry, and infrared methods. In addition, the effect of simulated gastric and intestinal 
fluid on DF drug was studied and it was found that this drug undergoes an enzyme-catalyzed 
hydrolysis in the intestines to its active form (diloxanide) and furic acid.        
5.1 Experimental Data: 
 
Experimental data on Diloxanide Furoate stability were collected and all the three mathematical 
models (linear regression, artificial neural network, and mechanistic models) were conducted on 
these data to determine the model that best predicts its stability. A comparison among these three 
mathematical models was made at the end to conclude the best statistical method that should be 
adopted in practice to achieve the most accurate shelf life. 
Table [5.1] shows both independent variables (temperature and time) at pH=8.0 and dependent 
variables (percentage of Diloxanide Furoate remaining).  
Table [5. 1]: Effect of Temperature and Time on the %DF Remaining 







336 0 100 
336 5.4095 79.5463 
336 10.305 63.7309 
336 15.2084 46.5246 
336 20.4931 35.456 
336 25.6549 25.3355 
336 30.1576 22.2756 
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336 35.3242 15.0321 
336 41 11.1322 
336 45.8973 8.363 
336 50.409 6.605 
328 0 100 
328 10.6751 76.2062 
328 20.7097 57.248 
328 30.6184 41.7946 
328 40.6548 30.7312 
328 50.6906 22.7583 
328 70.5163 10.9742 
323 0 100 
323 15.5551 76.9946 
323 30.4649 56.4352 
323 45.8881 43.3162 
323 60.6726 32.0782 
323 75.072 23.7564 
323 90 17.4678 
313 0 100 
313 20.801 89.6004 
313 40.1926 77.4819 
313 60.6146 64.1874 
313 80.0062 55.634 




5.2 RESULTS AND DISCUSSION: 
 
5.2.1 Linear Regression 
 
As it is known, the linear regression is concerned with models that are linear in parameters. In 
this experiment, the values of the independent variables are perfectly known and we want to 
create a model to estimate the unknown parameters. 
The coefficient of determination was found to be 93.1266% and the standard error was 8.421122 
as shown in Table [5.2]. This result indicates that the model highly represents the data.  
Table [5. 2]: Statistical Results of Regression Model 
Regression Statistics 
Multiple R 0.965073 
R square 0.931366 
Adjusted R square 0.92374 
Standard Error 8.421122 
Observations 31 
 
Table [5. 3]: ANOVA TABLE 
Source of variance DF SS MS F critical F Significance  
Regression 3 25982.78 8660.926 122.1306 8.1E-16 
Residual 27 1914.713 70.91529   




The underlying model: 
Table [5.4] represents the ANOVA table and show the parameters that have significant effects in 
the regression. 






t observed P-Value Lower 95% Upper 95% 
Intercept       (β0) 136.6907 17.04501 8.019395 1.28E-08 101.7172 171.6642 
Temp.           (β1) 1.412406 0.359157 3.932557 0.000529 0.675477 2.149336 
Time             (β2)     -0.89834 0.312237 -2.8771 0.007748 -1.53899 -0.25768 
Temp*time   (β3) -0.04816 0.00718 -6.70726 3.36E-07 -0.06289 -0.03342 
tcritical = 2.776445 
General regression model  
  =β0+ β1X1+ β2X2+ β3X1X2+ε                                 where   ~N(0, 
2
) 
Fitted linear regression model         
 = 136.6907–1.412406X1– 0.89834X2– 0.04816X1X2 +   
Model Evaluation:  
To test the validity of the underlying assumption (error ~N(0, 2) as a diagnostic check we are  
going to look at the residuals, normal probability plots from the fitted model. Also, it is 
important to determining the coefficient of determination to measure how well the linear 
regression model represents the data. 
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 Residual Plots 
Using the residual plots is to investigate whether the errors are scattered, independent and 
normally distributed.  
 
Figure [5. 1]: Diloxanide furoate Residual Plot 
We can see from the figure 4 that the residual has a random pattern, and can be assumed that are 
from a normal distribution. As a result, the statistical approach is valid. 
 Normal probability plot: 
Using normal probability plots to investigate whether the error are normally distributed. 



















Figure [5. 2]: Diloxanide furoate Normal Probability Plot  
What is shown in Figure [5.2] is that the normal probability plot shows a straight line. So, we 
can assume that the observed sample comes from a normal distribution. 
 Coefficient of Determination (R2) 
Using the coefficient of determination as a diagnostic check is to measure whether the regression 
line represents the data. 
From the results, it is shown that R
2 
= 0.93, which means that 93.1366% of the total variation in 
observed sample can be explained by the linear relationship between the regressors and observed 
response y as it is described by the regression model.  Only 6.86 % of the total variation in the 
observed sample is unexplained. 

























5.2.2 Artificial Neural Network (ANN) 
 
Back propagation feed forward based on Levenberg-Marquadt training algorithm was employed 
to train the network. MATLAB® neural network toolbox was used to train and simulate the 
network model. Log sigmoid was found to give reasonable response.  
The data was randomly divided into a 25 training set and a 6 testing set as shown in Tables [5.5] 
and [5.6]. About 10 – 15 % of the data was selected randomly to be the testing data set. Then 









     
,so that, the inputs and outputs are belong to the interval [0, 1].   
Table [5. 5]: A Training Data Set     
Training Data Set 
Temperature(K)  Time (minutes)  %DF Remaining 
313 60.6146 64.1874 
336 5.4095 79.5463 
328 50.4090 6.6050 
323 60.6726 32.0782 
336 0 100 
336 41 11.1322 
328 0 100 
313 20.8010 89.6004 
323 70.5163 10.9742 
336 20.4931 35.4560 
336 25.6549 25.3355 
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328 40.6548 30.7312 
336 35.3242 15.0321 
313 100 47.3053 
336 30.1567 22.2756 
328 10.6751 76.2062 
336 10.3050 63.7309 
313 40.1926 77.4819 
323 75.0720 23.7564 
328 20.7097 57.2480 
323 50.6906 22.7583 
323 30.4649 56.4352 
323 45.8881 43.3162 
336 15.2084 46.5246 
328 30.6184 41.7946 
 
Table [5. 6]: A Testing Data Set 
Testing set data 
Temperature(K) Time (minutes) %DF Remaining 
336 45.8973 8.3630 
323 0 100 
323 15.5551 76.9946 
323 90 17.4678 
313 0 100 




The result was acceptable by using 500 epochs of training, with the goal 10
-5
 and 5 neurons and 
one hidden layer. The log sigmoid function was applied on this set of data. 
The coefficient of determination (R
2
)  was 99.214% for training data set and 98.756% for the 
testing data set as shown in the Tables [5.7] and [5.8] respectively. Since the coefficient 
approaches 1, it indicates an excellent predictive ability of the neural network model. 
Table [5. 7]: Statistical Properties for Training Data Set 
Average error 5.55825 
Maximum error 32.13496 





Table [5. 8]: Statistical Properties for Testing Data Set 
Average error 12.72280 
Maximum error 52.39252 







As it is shown in Figure [5.3], most of the observed and predicted values are located on the 
parity line on the scatter plot which means that the predicted values of y are very close to the 































Although there was no enogh data to be used for both training and testing as it can be seen in the 
Figure [5.4], still the closeness of the few points to the parity line implying that the ANN 
techniques has functioned well.  
 
 
























The Figure [5.5] shows the distribution of the errors. It shows a major part of the errors are 
between 1% and 10%. 
 
Figure [5. 5]: Diloxanide Furoate Histogram  
 
5.2.3 Mechanistic Model 
 
 Microsoft Office Excel© version 2007 was used for mechanistic model calculations in this 
research. A mechanistic model for diloxanide furoate was proposed as shown in Equation [5.1] 
and both of the rate constant and the rate order were determined at different temperatures using a 
linear regression methods.  
-ra = kA CA
α
                                                                                                                          [eq5.1] 













The Equation [5.1] was linearized as: 
ln(-ra) = ln(kA)+α
 
lnCA                                                                                                         [eq5.2] 
The results are summarized in Table [5.9]. 
Table [5. 9]: Reaction Rate Constants (k) for Diloxanide Furoate Degradation at Various 
Temperatures 
Temperature(K) Reaction Rate Constant kA (min.
-1
) Reaction Order (α) 
336 0.054201 0.9878 
328 0.006682 1.0811 
323 0.013702 1.0163 
313 0.001583 1.0214 
 
It was found that the mean of squared errors is 1.7x10
-5 
and the coefficient of determination was 
95.40%. 
The rate of the reaction follows a first order kinetics. The natural logarithm of observed rate 
constants over the temperature range of 40-63°C (313-338K) were plotted versus reciprocal of 
temperature according to the Arrhenius equation to calculate the frequency factor and the  
activation energy. The activation energy was calculated from the slope of the straight line 
obtained by linear regression method was found to be 16.304043 Kcal/mole and the frequency 






HARDNESS OF UNCOATED TABLET (X) 
 
Hardness of tablet drug products is one of the most important physical characteristics that need 
to be maintained throughout the process of packaging and storage until used. Hardness in is 
defined as the force required to break the tablet in diametrical compression test, and hence it is 
used in pharmaceutical industry as a measurement of the solid dosage forms stability and 
resistance to breakdown by any of the stress factors. Hardness has to be tested by exposing the 
drug tablets to variable degrees of temperature and relative humidity over a defined period of 
time to determine the best environmental conditions to be provided so that the tablets remain 
stable and strong enough until their use by consumers.  
In the following case study, the experimental data for the hardness of uncoated drug tablets were 
taken from the thesis “Designing A Package For Pharmaceutical Tablets in Relation to Moisture 
and Dissolution” by Yoon Seungyil (39). 
This experiment was carried out to investigate the compressive strength (effect of intermolecular 
forces among the ingredients on tablets) and detecting tablet fracture. Tablets were stored at 
different relative humidity, two different temperatures (25°C and 40°C). Then the hardness of 
tablets was measured at different time intervals by using Strength Testing Machines.   
6.1 Experimental Data: 
 
Experimental data on hardness of uncoated drug tablets were collected and all the three 
mathematical models (linear regression, artificial neural network, and mechanistic models) were 
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conducted on these data to determine the model that best predicts its stability. A comparison 
among these three mathematical models was made at the end to conclude the best statistical 
method that should be adopted in practice to achieve the most accurate shelf life. 
Table [6.1] shows independent variables (temperature, time, relative humidity) and dependent 
variable (hardness of tablets). 
Table [6. 1]: Effect of Temperature, Relative Humidity and Time on Hardness 
                                        Independent Variables Dependent Variable 
Te perature (   )  Relative Humidity (RH%) Time ( Days)  Hardness (Kp) 
 
298 90 0 9.2 
298 90 6 2.4 
298 90 18 1.8 
298 90 70 8.1 
298 90 100 1.6 
298 90 130 1.9 
298 90 170 1.9 
298 90 190 1.9 
298 75 0 9.2 
298 75 6 7.6 
298 75 18 7.3 
298 75 70 8 
298 75 100 7.5 
298 75 130 7.9 
298 75 170 7.9 
298 75 190 8.4 
298 65 0 9.2 
298 65 6 9.2 
298 65 18 8 
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298 65 70 8.2 
298 65 100 9.5 
298 65 130 9.2 
298 65 170 9.7 
298 65 190 9.6 
298 50 0 9.2 
298 50 6 8.2 
298 50 18 8.2 
298 50 70 8.8 
298 50 100 9 
298 50 130 9.3 
298 50 170 9.2 
298 50 190 9.2 
298 0 0 9.2 
298 0 6 8.4 
298 0 18 8.2 
298 0 70 8.3 
298 0 100 8 
298 0 130 8.4 
298 0 170 8 
298 0 190 8 
313 90 0 9.2 
313 90 6 2.5 
313 90 18 2.6 
313 90 70 2.5 
313 90 100 2.6 
313 90 130 2.8 
313 90 170 3 
313 90 190 3 
313 75 0 9.2 
313 75 6 7.5 
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313 75 18 8 
313 75 70 8.4 
313 75 100 8.7 
313 75 130 9 
313 75 170 9.2 
313 75 190 9.3 
313 65 0 9.2 
313 65 6 8.6 
313 65 18 9.1 
313 65 70 9.7 
313 65 100 9.9 
313 65 130 10 
313 65 170 10.9 
313 65 190 10.3 
313 50 0 9.2 
313 50 6 8.9 
313 50 18 10.2 
313 50 70 10.6 
313 50 100 10.3 
313 50 130 10.8 
313 50 170 11.2 
313 50 190 11.2 
313 0 0 9.2 
313 0 6 8.2 
313 0 18 8.4 
313 0 70 8.4 
313 0 100 8.3 
313 0 130 8.6 
313 0 170 8.4 
313 0 190 8.6 
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6.2 RESULT AND DISCUSSION  
 
6.2.1 Linear Regression 
 
As it is known, the linear regression is concerned with models that are linear in parameters. In 
this experiment, the values of the independent variables are perfectly known and we want to 
create a model to estimate the unknown parameters. 
Tentatively, a linear regression model has been fitted to the experimental data. However, it has 
been found that the linear model is not adequate since it failed the diagnostic test such as 
residual plots and normal probability plots as seen in Figure [6.1] and [6.2], respectively. 
Therefore, nonlinear empirical models such as a neural network have been investigated. 
 
Figure [6. 1]: Uncoated Tablets Residual Plot  















Figure [6. 2]: Uncoated Tablets Normal Probability Plot  
6.2.2 Artificial Neural Network (ANN) 
 
Back propagation feed forward based on Levenberg-Marquadt training algorithm was employed 
to train the network. MATLAB® neural network toolbox was used to train and simulate the 
network model. Log sigmoid was found to give reasonable response by trying different 
activation functions.  
The data was randomly divided into a 70 training set and a 10 testing set as shown in tables [6.2] 
and [6.3]. About 10 – 15 % of the data was selected randomly to be the testing data set. Then 









     
























So that, the inputs and outputs are belong to the interval [0, 1]. 
Table [6. 2]: A Training Data Set of Uncoated Tablet     
Training Data Set 
Temperature (K) Relative Humidity (RH%) Time (Days) Hardness (kp) 
298 90 0 9.2 
298 90 6 2.4 
298 90 18 1.8 
298 90 70 8.1 
298 90 100 1.6 
298 90 130 1.9 
298 90 170 1.9 
298 75 0 9.2 
298 75 6 7.6 
298 75 18 7.3 
298 75 70 8 
298 75 130 7.9 
298 75 170 7.9 
298 75 190 8.4 
298 65 0 9.2 
298 65 6 9.2 
298 65 18 8 
298 65 70 8.2 
298 65 100 9.5 
298 65 130 9.2 
298 65 190 9.6 
298 50 0 9.2 
298 50 6 8.2 
298 50 18 8.2 
298 50 70 8.8 
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298 50 130 9.3 
298 50 170 9.2 
298 50 190 9.2 
298 0 0 9.2 
298 0 6 8.4 
298 0 18 8.2 
298 0 100 8 
298 0 130 8.4 
298 0 170 8 
298 0 190 8 
313 90 0 9.2 
313 90 6 2.5 
313 90 18 2.6 
313 90 70 2.5 
313 90 130 2.8 
313 90 170 3 
313 90 190 3 
313 75 0 9.2 
313 75 6 7.5 
313 75 18 8 
313 75 70 8.4 
313 75 100 8.7 
313 75 170 9.2 
313 75 190 9.3 
313 65 0 9.2 
313 65 6 8.6 
313 65 18 9.1 
313 65 70 9.7 
313 65 130 10 
313 65 170 10.9 
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313 65 190 10.3 
313 50 0 9.2 
313 50 6 8.9 
313 50 18 10.2 
313 50 100 10.3 
313 50 130 10.8 
313 50 170 11.2 
313 50 190 11.2 
313 0 0 9.2 
313 0 6 8.2 
313 0 18 8.4 
313 0 70 8.4 
313 0 100 8.3 
313 0 170 8.4 
313 0 190 8.6 
 
 
Table [6. 3]: A Testing Data Set of Uncoated Tablet  
Training Data Set 
 Temperature (K) Relative Humidity (RH%) Time (Days) 
 
Hardness (kp) 
298 90 130 1.9 
298 75 100 7.5 
298 65 170 9.7 
298 50 100 9 
298 0 100 8 
313 90 100 2.6 
313 75 130 9 
313 65 100 9.9 
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313 50 70 10.6 
313 0 130 8.6 
The result was acceptable by using 5000 epochs of training, with the goal 10
-5
 and 9 neurons and 
two hidden layers. The log sigmoid function was applied in this set of data. 
Table [6. 4]: Statistical Properties for Training Data Set 
Average error 3.25830        
Maximum error 24.40375              





Table [6. 5]: Statistical Properties for Testing Data Set 
Average error 8.08678        
Maximum error 17.32032              













The scatter plot in Figure [6.3] shows that the parity line passes through a great number of the 
observed and predicted values. This indicates a strong predictive ability of the neural network.   
 




























Because of lack of data points used for testing the trained neural network model, the model was 
not able to capture a clear relationship between the inputs and the output in the testing datasets 
as seen in Figure [6.4].This made it hard to judge the predictive ability of the trained network.  
 




























It was found that the frequency of the error distribution lies mostly in the range between 5-9% as 
shown in figure [6.5]. Also, there are substantial errors elsewhere. 
 
Figure [6. 5]: Uncoated Tablets Histogram  
 
6.2.3 Mechanistic Model 
 
In order to determine the predicted values with regards to the hardness of the uncoated tablets, 
the mechanistic model of Nakabayashi, K. et al (40) was used. This model relied on applying an 
iterative procedure where the influence of temperature and relative humidity over a time interval 
of several days is evaluated.    










The following equations were used for creating the mechanistic model: 
 
               
  
    
                                                                                                                     [eq6.1] 
                                                                                                                                   [eq6.2] 
                                                                                                                                [eq6.3] 
    
   
                     
                                                                                         [eq6.4] 
                                                                                                                                          [eq6.5] 
                                                                                                                                      [eq6.6] 
                                                                                                                                   [eq6.7] 
           
 
  
                                                                                                                              [eq6.8] 
                                                                                                                                              [eq6.9] 
                                                                                                                                             [eq6.10] 
                                                                                                                                          [eq6.11] 
 
Where; the subscript j denotes to the each time intervals, P is the permeability constant, E is the 
activation energy of moisture permeation, Vj is the saturated vapour pressure for the j-th interval, 
R is the rate constant,    is the heat of vaporization of water,     is the vapour pressure 
difference across the package,    is an absolute temperature, W is the weight of the tablets, S is 
the surface area of the tablet, L is the thickness of the tablet, N is the number of tablets per 
package, k is the rate constant,     is the apparent rate constant,       is the moisture content of the 
tablet for the j-th interval.                 
The MSE was found to be 17.36. This is a quite large value which obviously indicates that there 








Drug products can easily degrade with change in their composition and chemical and physical 
characters over time under the influence of variable environmental factors such as temperature, 
light and moisture. Such instability or degradation can lead to partial or complete loss of drug 
efficacy as a therapeutic agent or even a transformation into a toxic substance. This fact made 
the stability of drug substances and drug products to be considered as an important subject in 
pharmaceutical industry.  
Measuring the drug stability usually is as important as any of the other steps involved in the 
development process of any new product in pharmaceutical industry such as drug discovery, 
laboratory development, animal studies, clinical trials, and regulatory registration. Since the drug 
stability is a means of proving an evidence for its safety and efficacy, approval of any drug 
product by the regulatory agencies requires that the stability has to be provided prior to its 
release for public use. 
Stability testing requires vigorous work and lengthy studies. Analytical techniques have been the 
commonly used methods in drug stability testing. These techniques include high performance 
liquid chromatography (HLPC) or thin layer chromatography (HPTLC), gas chromatography 
(GC) and electrophoresis. Recently, there has been a new trend towards the use of statistical 
modelling techniques. The modelling techniques commonly used nowadays are the empirical 
models such as linear regression, artificial neural network, and the mechanistic models. Such 
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techniques are thought to be reliable and economic alternatives with the advantage of time 
saving.  
To assess the reliability and applicability of statistical modelling in studying drug stability and 
estimating its degradation with time and to know whether statistical modeling can efficiently 
substitute the ordinary analytical methods, several models were applied in this research on three 
different drugs. These drugs were chosen from the pharmaceutical literature. The concentration 
or hardness of these drugs over time was used as indicators of the drug stability. Three different 
models (linear regression, artificial neural network and mechanistic models) were implemented 
on each drug to predict the drug concentration over time. These predicted values were compared 
to the observed values and then evaluated by calculating the mean of square errors (MSE) to 
determine how close those values were to the exact values resulted experimentally. Moreover, 
the coefficient of determination (R
2
) was calculated to further evaluate the model accuracy as 
well. 
The first case study addressed the stability of acetyl salicylic acid (ASA) tablets. The 
concentration of ASA at variable temperatures (35, 40, 45, 50  C) was determined 
experimentally at different time intervals using HPLC. Firstly, a linear regression model was 
proposed and the unknown parameters were estimated and found to be significant as concluded 
from ANOVA table. The errors were found to be normally distributed with a mean equal to zero 
and the residuals residual had a random pattern as seen in normal probability and the residual 
plots, respectively. The MSE was 6.33, and R
2
 was 84.67%. This meant that the regression 
model represents the data very well. Secondly, the artificial neural network was applied and it 
was able to capture the relationships between the inputs and the output in the testing datasets in 





 was 94% indicating a high accuracy for artificial neural network model as well. 
The third model applied was the mechanistic model. This model was linearized to determine the 
decomposition rate constants (kApp) at various temperatures and the order of the reaction (α). The 
hydrolysis process was found to follow first order kinetic dependent only on the concentration of 
one reactant; i.e. aspirin.  The apparent activation energy of aspirin hydrolysis of 49 Kcal/mole 





 was 96.48% which indicates that the predicted values were very close to the observed 
values which in turn indicated that the mechanistic model is reliable. 
The second case studied the stability of diloxanide furoate (DF) in solution. The concentration of 
DF at variable temperatures (40, 50, 55, 63  C) was determined experimentally at different time 
intervals at pH 8 using HPLC. Firstly, a linear regression model was proposed and the unknown 
parameters were estimated and found to be significant as concluded from ANOVA table. The 
errors were found to be normally distributed with a mean equal to zero and the residuals had a 
random pattern as seen in normal probability and the residual plots, respectively. The MSE was 
70.91, and R
2
 was 93.13%. This meant that the regression model represents the data quite well. 
Secondly, the artificial neural network was implemented and it was able to capture the 
relationships between the inputs and the output in the testing datasets in spite of the limited 
number of the experimental data (31 data points). The MSE was 16.54 whereas the R
2
 was 
98.75% indicating a high accuracy for artificial neural network model as well. The third model 
applied was the mechanistic model. This model was linearized to determine the decomposition 
rate constants (kApp) at various temperatures and the order of the reaction (α). The hydrolysis 
process was found to follow first order kinetic. The apparent activation energy of DF hydrolysis 
of 16.30 Kcal/mole was calculated by using the Arrhenius equation method. This value of 
88 
 
activation energy lied within the accepted limits for hydrolysis of esters (8-20 Kcal/mole). MSE 
was found to be 1.7x10
-5
 and the R
2
 was 95.78% which indicates that the predicted values were 
very close to the observed values which in turn indicated that the mechanistic model is reliable.   
In the third case, the hardness of an uncoated drug tablet was tested experimentally by exposing 
the drug tablets to variable degrees of temperature and relative humidity over a defined period of 
time. When linear regression model was proposed, it was found to be inadequate as it failed the 
diagnostic tests (residual and normal probability plots) along with having R
2
 of 10%. This meant 
that the regression model could not represent the data. Therefore, a nonlinear empirical model 
which is the artificial neural network was applied. This model was able to capture the 
relationships between the inputs and the output in the testing datasets. The MSE was 0.5842 
whereas the R
2
 was 92.806% indicating reliable predictions of the performance of the process 
for artificial neural network model.  
When mechanistic model was applied, the MSE was found to be 17.36 which revealed a 
significant disagreement between the observed values and the predicted ones. This thought to be 
attributed to the sever fluctuation of the actual data.    
With regards to the advantages of mathematical models, they are clearly economic and time 
saving and mostly quite easy to perform. However, mechanistic models sometimes require a 
great deal of expertise as compared to the empirical models.     
One conclusion is that when linear regression model fails to achieve accurate predicted values, 
the non linear regression models such as artificial neural network could be reliably alternative 
thanks to its generalization ability whence the learning of network is successful. However, 
artificial neural network has the following disadvantages:  
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1) There is no systematic way to obtain an optimal architecture.  
2) It requires sufficiently large number of data points for training.  
3) There is no guarantee to obtain a global of optima which may require global optimization 
techniques to improve the solution (e.g. genetic algorithm).                                                      















7.2. Recommendation and Future Works 
 
 In general, prediction models can be classified into three types: first-principles models, 
empirical models and semi-empirical models.  Each of these models is further characterized, 
based on the nature of the correlation between variables and linear or nonlinear models.  In this 
project we used first principles and empirical models to predict the drug stability. More 
specifically, linear, nonlinear and kinetics models have been used. Each of these model 
structures has its own advantages and disadvantages.   From model development point of view, a 
first principle-based model (kinetics) is usually difficult to be developed compared to the 
empirical-based models (e.g. linear regression and neural networks).  Future woks on the drug 
stability can be geared into two directions:  
1)  Investigating different empirical based models (linear/nonlinear) 
As a continuation of this project, other types of models should be examined.  For examples, 
subspace models, such as Partial Least Squares (PLS) has many attractive properties.  It is 
characterized by the ability to model multi response variables (e.g. active ingredient 
concentration, hardness) as a function of the input variables by maximizing the covariance 
between the input and output matrix (41). This is necessary and important especially when 
inputs and outputs are cross-correlated. The latter is typical in most of practical systems. In 
addition, subspace models are characterized by their filtering capabilities which can give more 
accurate predictions.  While PLS is an example of linear models, Support Vector Machine 
(SVM) arises as a strong competitive to Neural Networks based modeling.  The main 
advantageous of the SVM based models is the convexity of the regression problem compared to 
the NN-based modeling, where only suboptimal solutions can be found.  PLS and SVM have not 
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been investigated in the context of drug stability and exploring their capabilities would be of 
advantage. 
2) Implement the mathematical models on variables other than temperature and relative humidity 
to test the applicability of these models. For example, study the effect of pH and light on the 
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